Analysed CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) News Sources
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026
18-02-2026
yahoo.com
Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD’s Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions
05-11-2025
yahoo.com
Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community
28-10-2025
yahoo.com
Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United States
21-10-2025
yahoo.com
e.l.f. Beauty’s CDIO says she’s responsible for AI’s foundation, but that these tools aren’t an IT mandate
10-09-2025
yahoo.com
Cardio Diagnostics Holdings Second Quarter 2025 Earnings: US$0.97 loss per share (vs US$1.71 loss in 2Q 2024)
16-08-2025
yahoo.com
Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)
22-07-2025
yahoo.com
What is the current price of CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ)?
The current price of CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) is $0.0168.
CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) absolute price change since previous trading day?
The absolute price change of CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) since the previous trading day is $0.0007.
CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) percentage price change since previous trading day?
The percentage price change of CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) since the previous trading day is 4.3478%.
What is the most recent average sentiment score for CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ)?
The most recent average sentiment score for CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ)?
The most recent sentiment for CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) is .
SEC-8K** Filing Available For CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.